Literature DB >> 29110329

Transplantation of feeder-free human induced pluripotent stem cell-derived cortical neuron progenitors in adult male Wistar rats with focal brain ischemia.

Yulius Hermanto1,2,3, Tadashi Sunohara1,2, Ahmad Faried3, Yasushi Takagi4, Jun Takahashi2, Takakuni Maki5, Susumu Miyamoto1.   

Abstract

The use of human induced pluripotent stem cells (hiPSCs) eliminates the ethical issues associated with fetal or embryonic materials, thus allowing progress in cell therapy research for ischemic stroke. Strict regulation of cell therapy development requires the xeno-free condition to eliminate clinical complications. Maintenance of hiPSCs with feeder-free condition presents a higher degree of spontaneous differentiation in comparison with conventional cultures. Therefore, feeder-free derivation might be not ideal for developing transplantable hiPSC derivatives. We developed the feeder-free condition for differentiation of cortical neurons from hiPSCs. Then, we evaluated the cells' characteristics upon transplantation into the sham and focal brain ischemia on adult male Wistar rats. Grafts in lesioned brains demonstrated polarized reactivity toward the ischemic border, indicated by directional preferences in axonal outgrowth and cellular migration, with no influence on graft survival. Following the transplantation, forelimb asymmetry was better restored compared with controls. Herein, we provide evidence to support the use of the xeno-free condition for the development of cell therapy for ischemic stroke.
© 2017 Wiley Periodicals, Inc.

Entities:  

Keywords:  cell therapy; human pluripotent stem cells; ischemic stroke; neural stem cells

Year:  2017        PMID: 29110329     DOI: 10.1002/jnr.24197

Source DB:  PubMed          Journal:  J Neurosci Res        ISSN: 0360-4012            Impact factor:   4.164


  5 in total

1.  An integrated biomanufacturing platform for the large-scale expansion and neuronal differentiation of human pluripotent stem cell-derived neural progenitor cells.

Authors:  Gayathri Srinivasan; Daylin Morgan; Divya Varun; Nicholas Brookhouser; David A Brafman
Journal:  Acta Biomater       Date:  2018-05-15       Impact factor: 8.947

Review 2.  Pluripotent Stem Cells for Brain Repair: Protocols and Preclinical Applications in Cortical and Hippocampal Pathologies.

Authors:  Claudia Alia; Marco Terrigno; Irene Busti; Federico Cremisi; Matteo Caleo
Journal:  Front Neurosci       Date:  2019-08-06       Impact factor: 4.677

Review 3.  Human Pluripotent Stem Cells-Based Therapies for Neurodegenerative Diseases: Current Status and Challenges.

Authors:  Elizabeth Ford; Jodie Pearlman; Travis Ruan; John Manion; Matthew Waller; Gregory G Neely; Leslie Caron
Journal:  Cells       Date:  2020-11-20       Impact factor: 6.600

4.  Multimodal Therapeutic Effects of Neural Precursor Cells Derived from Human-Induced Pluripotent Stem Cells through Episomal Plasmid-Based Reprogramming in a Rodent Model of Ischemic Stroke.

Authors:  Seung-Hun Oh; Yong-Woo Jeong; Wankyu Choi; Jeong-Eun Noh; Suji Lee; Hyun-Sook Kim; Jihwan Song
Journal:  Stem Cells Int       Date:  2020-03-23       Impact factor: 5.443

Review 5.  Recent Advances in Mono- and Combined Stem Cell Therapies of Stroke in Animal Models and Humans.

Authors:  Roxana Surugiu; Andrei Olaru; Dirk M Hermann; Daniela Glavan; Bogdan Catalin; Aurel Popa-Wagner
Journal:  Int J Mol Sci       Date:  2019-11-29       Impact factor: 5.923

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.